Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only

Home/IN/Evansville

Updated September 2026 from ClinicalTrials.gov

Paid Clinical Trials in Evansville, IN

Studies commonly pay $75 to $4,500 per completed study

68 clinical trials are currently recruiting participants within 30 miles of Evansville. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

68studies recruiting

2+research centers nearby

7condition categories

Live from the NIH registry

Studies recruiting near Evansville right now

Top 25 of 68 recruiting studies, sorted by proximity — each links to its official registry page

BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease

HR+/HER2- Breast Cancer Phase 3 Interventional 1,056 participants sought

Owensboro Health Mitchell Memorial Cancer Center — Owensboro, Kentucky (27.3 mi) · Sponsor: BeOne Medicines

See eligibility & contact on ClinicalTrials.gov (NCT07492641)

Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain

Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma Phase 3 Interventional 269 participants sought

Owensboro Health Mitchell Memorial Cancer Center — Owensboro, Kentucky (27.3 mi) · Sponsor: NRG Oncology

See eligibility & contact on ClinicalTrials.gov (NCT06500455)

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

Diabetes Mellitus, Type 2, Hypertension Phase 3 Interventional 11,800 participants sought

Research Integrity, LLC — Owensboro, Kentucky (27.3 mi) · Sponsor: Boehringer Ingelheim

See eligibility & contact on ClinicalTrials.gov (NCT07064473)

A Study Assessing Long-Term Safety and Effectiveness in Treatment Management of Atrial Fibrillation With VARIPULSE Catheter System

Atrial Fibrillation N/A Interventional 276 participants sought

Deaconess Gateway Hospital — Newburgh, Indiana (7.6 mi) · Sponsor: Biosense Webster, Inc.

See eligibility & contact on ClinicalTrials.gov (NCT07227532)

EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)

Breast Cancer N/A Observational 1,800 participants sought

Deaconess Chancellor Center for Oncology — Newburgh, Indiana (7.6 mi) · Sponsor: Exact Sciences Corporation

See eligibility & contact on ClinicalTrials.gov (NCT06401421)

A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Phase 3 Interventional 1,200 participants sought

Owensboro Medical Health System ( Site 0066) — Owensboro, Kentucky (27.3 mi) · Sponsor: Merck Sharp & Dohme LLC

See eligibility & contact on ClinicalTrials.gov (NCT06136559)

A Phase 3 Study of Rezpegaldesleukin (NKTR-358) for Patients ≥ 12 Years of Age With Moderate-to-Severe Atopic Dermatitis

Moderate-to-Severe Atopic Dermatitis Phase 3 Interventional 510 participants sought

Nektar Investigative Site — Owensboro, Kentucky (27.3 mi) · Sponsor: Nektar Therapeutics

See eligibility & contact on ClinicalTrials.gov (NCT07690371)

ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults

Asthma Phase 2 Interventional 50 participants sought

Enveda Investigative Site — Owensboro, Kentucky (27.3 mi) · Sponsor: Enveda Therapeutics

See eligibility & contact on ClinicalTrials.gov (NCT07301255)

Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease

High Risk Cardiovascular Disease, Hypertension Phase 3 Interventional 11,000 participants sought

Clinical Trial Site — Evansville, Indiana (1.5 mi) · Sponsor: Alnylam Pharmaceuticals

See eligibility & contact on ClinicalTrials.gov (NCT07181109)

Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS

Acute Coronary Syndrome Phase 3 Interventional 2,000 participants sought

Research Site — Newburgh, Indiana (7.6 mi) · Sponsor: DalCor Pharmaceuticals

See eligibility & contact on ClinicalTrials.gov (NCT05918861)

A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer

Small Cell Lung Cancer Phase 3 Interventional 531 participants sought

Deaconess Midtown Hospital /ID# 282134 — Evansville, Indiana (1.5 mi) · Sponsor: AbbVie

See eligibility & contact on ClinicalTrials.gov (NCT07365241)

RELIEF - A Global Prospective Observational Post-Market Study to Evaluate Long-Term Effectiveness of Neurostimulation Therapy for Pain

Pain N/A Observational 4,800 participants sought

Global Scientific Innovations - Advanced Pain Care Clinic — Evansville, Indiana (1.5 mi) · Sponsor: Boston Scientific Corporation

See eligibility & contact on ClinicalTrials.gov (NCT01719055)

A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years

Chronic Migraine Phase 3 Interventional 420 participants sought

Deaconess Midtown Hospital /ID# 270572 — Evansville, Indiana (1.5 mi) · Sponsor: AbbVie

See eligibility & contact on ClinicalTrials.gov (NCT06810505)

Device for Treating Generalized Anxiety

Generalized Anxiety Disorder (GAD) N/A Interventional 40 participants sought

Cady Wellness Institute — Newburgh, Indiana (7.6 mi) · Sponsor: BTL Industries Ltd.

See eligibility & contact on ClinicalTrials.gov (NCT07819773)

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

Osteoarthritis, Overweight or Obesity Phase 3 Interventional 900 participants sought

Qualmedica Research, LLC — Evansville, Indiana (1.5 mi) · Sponsor: Eli Lilly and Company

See eligibility & contact on ClinicalTrials.gov (NCT07353931)

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

Obesity, Overweight Phase 3 Interventional 1,560 participants sought

AURORA-2 Clinical Site — Evansville, Indiana (1.5 mi) · Sponsor: Ascletis Pharma (China) Co., Limited

See eligibility & contact on ClinicalTrials.gov (NCT07743450)

E-Mindfulness Approaches for Living After Breast Cancer

Breast Cancer, Depression Phase 3 Interventional 402 participants sought

Owensboro Health Mitchell Memorial Cancer Center — Owensboro, Kentucky (27.3 mi) · Sponsor: NRG Oncology

See eligibility & contact on ClinicalTrials.gov (NCT06748222)

Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis: A Randomized, Placebo Controlled Study

Moderate Aortic Valve Stenosis Phase 2, Phase 3 Interventional 1,276 participants sought

The Heart Hospital at Deaconess Gateway — Newburgh, Indiana (7.6 mi) · Sponsor: Kardigan, Inc.

See eligibility & contact on ClinicalTrials.gov (NCT07001800)

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)

Chronic Obstructive Pulmonary Disease (COPD) Phase 3 Interventional 990 participants sought

Research Site — Evansville, Indiana (1.5 mi) · Sponsor: AstraZeneca

See eligibility & contact on ClinicalTrials.gov (NCT06878261)

Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction

Heart Failure, Heart Failure With Reduced Ejection Fraction Phase 3 Interventional 1,800 participants sought

Deaconess Heart Group — Newburgh, Indiana (7.6 mi) · Sponsor: Cytokinetics

See eligibility & contact on ClinicalTrials.gov (NCT06736574)

A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF

Heart Failure With Preserved Ejection Fraction (HFpEF), Heart Failure With Mildly Reduced Ejection Fraction (HFmrEF) Phase 3 Interventional 6,950 participants sought

Research Site — Owensboro, Kentucky (27.3 mi) · Sponsor: AstraZeneca

See eligibility & contact on ClinicalTrials.gov (NCT07761117)

A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine

Episodic Migraine Phase 3 Interventional 450 participants sought

Deaconess Clinic - Gateway Health Center /ID# 247589 — Newburgh, Indiana (7.6 mi) · Sponsor: AbbVie

See eligibility & contact on ClinicalTrials.gov (NCT05711394)

Study of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously Treated Extensive Stage Small Cell Lung Cancer

Extensive Stage Small Cell Lung Cancer (ES-SCLC) Phase 3 Interventional 695 participants sought

Owensboro Health Mitchell Memorial Cancer Center — Owensboro, Kentucky (27.3 mi) · Sponsor: Gilead Sciences

See eligibility & contact on ClinicalTrials.gov (NCT06801834)

Persona Revision Knee System Outcomes

Arthroplasty Complications, Infection N/A Observational 380 participants sought

Orthopaedic Associates, Inc. — Evansville, Indiana (1.5 mi) · Sponsor: Zimmer Biomet

See eligibility & contact on ClinicalTrials.gov (NCT04821154)

Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD

Attention-Deficit/Hyperactivity Disorder Phase 4 Interventional 286 participants sought

Qualmedica Research, LLC. — Evansville, Indiana (1.5 mi) · Sponsor: Supernus Pharmaceuticals, Inc.

See eligibility & contact on ClinicalTrials.gov (NCT04781140)

Actively enrolling

Studies you may be able to join near Evansville

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

Research study for alcohol-related liver damage

Enrolling US adults aged 18 to 70 with alcohol-induced liver damage and a history of heavy drinking. Not open to people with a recent stroke, heart attack, dialysis, or who take blood thinners.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Research study for bladder problems after spinal cord injury

This study is enrolling US adults aged 18 to 75 living with chronic involuntary bladder leakage caused by a spinal cord injury, for research including investigational gene therapy approaches. The study team confirms eligibility and any compensation before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Google-rated

Top-rated research centers in Evansville

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

MediSphere Medical Research Center

★ 5.0

4411 Washington Ave Ste 147, Evansville, IN 47714

(812) 471-4110

Website

"Good people who care about there people. For medical research ."

— Troy Christian, 5★

Qualmedica Research

5015 Plaza E Blvd, Evansville, IN 47715

(812) 205-2475

Website

Clinical trials in Evansville: what's recruiting

The Evansville area currently has 68 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Evansville, the most active research areas are:

Cancer & Oncology7 studies
Heart & Vascular4 studies
Diabetes & Metabolism3 studies
Immune & Skin3 studies
Lungs & Breathing2 studies

Every listing shows the study phase, the recruiting site and its distance from Evansville, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Evansville

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Evansville participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Evansville pay?

Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.

Are clinical trials in Evansville safe?

Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.

How do I join a study in Evansville, IN?

Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.

How often do new paid studies open in Evansville?

Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Evansville.

Can I be in more than one clinical trial at a time?

Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Evansville typically complete one or two studies per year.

Paid clinical trials near Evansville

Other metros within reach

Clarksville, TN8 Louisville, KY557 Nashville, TN1,331 Champaign, IL168 Indianapolis, IN921 Murfreesboro, TN79 Lafayette, IN36 Springfield, IL181

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Evansville Bladder Issues Due To Spinal Cord Injury in Evansville All conditions

More of IN

Indianapolis921 Fort Wayne118 Elkhart105 South Bend105 Lafayette36

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

Get free trial alerts